The changing landscape of phase II/III metastatic sarcoma clinical trials—analysis of ClinicalTrials.gov

BACKGROUND: Well-designed clinical trials are of great importance in validating novel treatments and ensuring an evidence-based approach for sarcoma. This study aimed to provide a comprehensive landscape of the characteristics of metastatic or advanced sarcoma clinical trials using the substantial r...

Descripción completa

Detalles Bibliográficos
Autores principales: Que, Y, Xiao, W, Xu, BS, Wen, XZ, Weng, DS, Zhang, X
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293634/
https://www.ncbi.nlm.nih.gov/pubmed/30545340
http://dx.doi.org/10.1186/s12885-018-5163-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6293634/
https://www.ncbi.nlm.nih.gov/pubmed/30545340
http://dx.doi.org/10.1186/s12885-018-5163-2

Ejemplares similares